Literature DB >> 6605724

Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family.

L A Scheving.   

Abstract

Sequence similarities are detected between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of the secretin family of gastrointestinal hormones, particularly gastric inhibitory peptide. These similarities suggest a common evolutionary origin for these proteins and a possible functional relationship, as evidenced by the ability of human epidermal growth factor-urogastrone and human pancreatic secretory trypsin inhibitor to form a complex with protease and the ability of human epidermal growth factor-urogastrone and secretin family members to inhibit gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605724     DOI: 10.1016/0003-9861(83)90309-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion.

Authors:  B Agerberth; J Söderling-Barros; H Jörnvall; Z W Chen; C G Ostenson; S Efendić; V Mutt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution.

Authors:  T Marchbank; R Chinery; A M Hanby; R Poulsom; G Elia; R J Playford
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Therapeutic targeting of SPINK1-positive prostate cancer.

Authors:  Bushra Ateeq; Scott A Tomlins; Bharathi Laxman; Irfan A Asangani; Qi Cao; Xuhong Cao; Yong Li; Xiaoju Wang; Felix Y Feng; Kenneth J Pienta; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Sci Transl Med       Date:  2011-03-02       Impact factor: 17.956

5.  Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized fetal lambs.

Authors:  D H Polk; M G Ervin; J F Padbury; R W Lam; A L Reviczky; D A Fisher
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

6.  Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.

Authors:  M Bohe; C G Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

7.  Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.

Authors:  Tania Marchbank; Asif Mahmood; Anthony J Fitzgerald; Jan Domin; Matt Butler; Robert A Goodlad; George Elia; Helen M Cox; David A van Heel; Subrata Ghosh; Raymond J Playford
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

8.  Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development.

Authors:  Jun Wang; Masaki Ohmuraya; Masahiko Hirota; Hideo Baba; Gang Zhao; Motohiro Takeya; Kimi Araki; Ken-ichi Yamamura
Journal:  Histochem Cell Biol       Date:  2008-04-02       Impact factor: 4.304

9.  Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.

Authors:  R J Playford; A M Hanby; K Patel; J Calam
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

10.  The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.

Authors:  K Satake; A Inui; T Sogabe; Y Yoshii; B Nakata; H Tanaka; Y S Chung; A Hiura; K Umeyama
Journal:  Int J Pancreatol       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.